GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Predictors of treatment outcomes in patients with advanced ovarian cancer
Date
22 Sep 2020Session
GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidencePresenters
Bradley MonkAuthors
B.J. MonkAuthor affiliations
- Gynecologic Oncology Department, Arizona Oncology (US Oncology Network), 85016 - Phoenix/US
Resources
Resources from the same session
Evaluating first-line maintenance therapy options
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
The role of genetic testing in the treatment decision-making process
Presenter: Kathleen Moore
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
PARPi in the treatment of recurrent disease
Presenter: Jonathan Ledermann
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Introduction
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Live Q&A - 24 September 2020 - 16:15-16:45
Presenter: Bradley Monk
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.